BISTTRY13:43Live
MEDTR Stock Analysis and CommentaryMeditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.
- Volume
- TRY 1.3M
- Day range
- 16.65 – 17.50
- Previous close
- 17.08
- Market cap
- TRY 2.1B
Last updated: Source: Borsa Istanbul, 15-minute delayed
At a Glance: MEDTR Stock
- The MEDTR share price was TRY 17.43 as of November 2, 2026, a daily change of 2.05%.
- According to Yatırımcı.AI data, the company has a market cap of TRY 2.1B, a P/E of 59.68 and a P/B of 0.62.
- 52-week price range: TRY 16.36 – 34.10; one-year change −42.98%.
- Average price target of 2 brokers: TRY 39.25, 125.19% versus the last price.
- Latest dividend: gross TRY 0.11 per share paid on October 27, 2026.
- Latest financial statements: Q2 2026, published on KAP (Public Disclosure Platform) on August 14, 2026.
What is the MEDTR share price?
MEDTR (Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.) was at TRY 17.43 as of November 2, 2026, a daily change of 2.05%. Prices are delayed by 15 minutes.
What are the MEDTR P/E and P/B ratios?
MEDTR has a market cap of TRY 2.1B, a P/E of 59.68 and a P/B of 0.62. Ratios use the latest financial statements and the current price.
What is the MEDTR price target?
The average price target of 2 brokers for MEDTR is TRY 39.25, ranging from TRY 38.50 to TRY 40.00. Price targets are not investment advice.
Does MEDTR pay a dividend?
Latest dividend: gross TRY 0.11 per share paid on October 27, 2026.
Key Stats
- Day range
- 16.6517.50
- 52 weeks
- 16.3634.10
- Previous close
- 17.08
- Volume
- TRY 1.3M
- Weighted avg.
- 16.95
- Market cap
- TRY 2.1B
- P/E
- 59.68
- P/B
- 0.62
- EV/EBITDA
- 6.67
- Dividend yield
- 0.66%
- Free float
- 20.21%
- Analyst avg. target
- 39.25125.19%
- Paid-in capital
- TRY 119M
Set a price alert for MEDTR
Add MEDTR to your watchlist with a free account and get notified when it reaches your price.
- Follow funds and stocks in one watchlist
- An in-app notification and an email when a target is hit
- 3 active price alerts on the free plan
My Notes
MEDTR Company Profile
Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades on Borsa Istanbul under the ticker MEDTR. Field of activity as filed with KAP (in Turkish): Şirketin amacı, tıbbi cihaz sayılan solunum sistemleri ve infüzyon sistemlerinin, ameliyat ipliklerinin ve biyosidal ürünlerin üretimi ve yurtiçi ve yurtdışı satışı ile ilaç hazırlama ve uygulama hizmetleri ile bu faaliyetlerde gereken teknik servis, bakım, kalibrasyon hizmetlerini vermektir.
- Head office
- İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak NO:29 Tire-İzmir
- Chair of the board
- Atilla Sevinçli
- Website
- meditera.com.tr
- Subsidiaries and affiliates
- 4 companies
Shareholder structure
- Atilla Sevinçli
- 56.38%
- Mert Sevinçli
- 23.03%
- Other
- 20.59%
MEDTR Price Performance
- 1 week
- 2.37%
- 1 month
- −2.25%
- 3 months
- −30.04%
- Year to date
- −38.72%
- 1 year
- −42.98%
- 52-week high
- 34.10
- 52-week low
- 16.36
- Distance from 52-week high
- −48.89%
- Volume vs 20-session average
- 0.4×
- Rank among the day’s gainers
- 75 / 626
- Rank by traded value
- 557 / 626
MEDTR Stock Summary (Nov 2, 2026)
Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. (MEDTR) traded at TRY 17.43 as of 02/11/2026, a daily change of 2.05%. In the 02/11/2026 session, MEDTR ranked #75 among the top gainers and #557 by traded value out of 626 traded stocks. The share price changed 2.37% over the past week, −2.25% over the past month, −38.72% year to date and −42.98% over the past year. The 52-week trading range is TRY 16.36 – 34.10. The last close is 48.89% below the 52-week high. The company has a market cap of TRY 2.1B, a P/E ratio of 59.68, a P/B ratio of 0.62 and a free float of 20.21%. The stock belongs to the Chemicals, Petroleum, Rubber and Plastics sector, trades on the Main Market and is a constituent of the BIST All Shares, XTUMY, BIST Main Market, BIST Participation All indices. The average price target of 2 brokers is TRY 39.25, implying 125.19% upside from the current price (0 buy, 2 hold, 0 sell). Our AI fair value model estimates TRY 25.36 (45.50%); model date July 21, 2026. Latest KAP disclosure (November 2, 2026): Özel Durum Açıklaması (Genel).
Upside to the average analyst target: 125.19%. Not investment advice.
Frequently Asked Questions
Is MEDTR stock a buy?
2 brokers rate it 0 buy, 2 hold, 0 sell, with an average target of TRY 39.25 (125.19% upside). This data is for information only as of Nov 2, 2026; it is not investment advice.
What is the MEDTR price target for 2026?
As of August 18, 2026, the average target of 2 brokers for MEDTR is TRY 39.25; the highest target is TRY 40.00 and the lowest is TRY 38.50. Our AI fair value model estimates TRY 25.36 (45.50%).
MEDTR stock today: what happened?
In the 02/11/2026 session MEDTR traded at TRY 17.43, a daily change of 2.05%, with a day range of TRY 16.65 – 17.50 and a turnover of TRY 1.3M. Previous close: TRY 17.08. Data is delayed by 15 minutes.
What is the MEDTR share price today?
MEDTR (Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.) is at TRY 17.43 as of 02/11/2026, a daily change of 2.05%. Prices are delayed by 15 minutes; live prices require a Plus membership.
Which company is MEDTR and what does it do?
Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades on Borsa Istanbul under the ticker MEDTR. Field of activity as filed with KAP (in Turkish): Şirketin amacı, tıbbi cihaz sayılan solunum sistemleri ve infüzyon sistemlerinin, ameliyat ipliklerinin ve biyosidal ürünlerin üretimi ve yurtiçi ve yurtdışı satışı ile ilaç hazırlama ve uygulama hizmetleri ile bu faaliyetlerde gereken teknik servis, bakım, kalibrasyon hizmetlerini vermektir. Head office: İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak NO:29 Tire-İzmir. Chair of the board: Atilla Sevinçli.
Who are the shareholders of MEDTR?
According to the capital structure filed with KAP, the shareholders of MEDTR are: Atilla Sevinçli (56.38%), Mert Sevinçli (23.03%), Other (20.59%).
How much has MEDTR changed over the past year?
The share price changed 2.37% over the past week, −2.25% over the past month, −38.72% year to date and −42.98% over the past year. The 52-week trading range is TRY 16.36 – 34.10. The last close is 48.89% below the 52-week high.
What are the P/E and P/B ratios of MEDTR?
MEDTR has a market cap of TRY 2.1B, a P/E ratio of 59.68, a P/B ratio of 0.62 and an EV/EBITDA of 6.67. Ratios use the latest reported financial statements and the current price.
Which sector and indices does MEDTR belong to?
Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades in the Chemicals, Petroleum, Rubber and Plastics sector on the Main Market market. Its indices: BIST All Shares, XTUMY, BIST Main Market, BIST Participation All, BIST Industrials, XSINS, BIST Chemicals, Petroleum, Plastics, XSIZM.
Is MEDTR eligible for the participation (Islamic) indices?
Yes. As of Nov 2, 2026, MEDTR is a constituent of the Borsa Istanbul participation indices, which cover companies that comply with interest-free finance principles: BIST Participation All. The current index period is October 2026–April 2027. Borsa Istanbul reviews participation index membership for the May–September and October–April periods; this is not investment advice.
What is the dividend yield of MEDTR?
The trailing dividend yield of MEDTR is calculated at 0.66%.
What does the AI say about MEDTR?
Our fair value model estimates TRY 25.36 for MEDTR, a difference of 45.50% from the current price. The model was updated on July 21, 2026. This is not investment advice.
Which stocks are similar to MEDTR?
Stocks trading alongside MEDTR in the Chemicals, Petroleum, Rubber and Plastics sector: TUPRS, GUBRF, SASA, PETKM, AKSA, ECILC, BRISA, ORZAX.
Where does the data on this page come from and how often is it updated?
Price, ratio and company data come from IdealData, a licensed Borsa Istanbul data vendor; analyst targets from broker research; AI indicators from Yatırımcı.AI models. Prices are delayed 15 minutes, ratios refresh daily and financial statements after each KAP disclosure.
Participation index coverage: Borsa Istanbul
Prepared by: Yatırımcı.AI Research TeamLast reviewed: Method: MethodologyEditorial policy